BioCSL begins shipping Afluria flu vaccine

KING OF PRUSSIA, Pa. — BioCSL on Tuesday announced that it has started shipping the seasonal influenza vaccine Afluria for the 2014-15 flu season. Providers in the United States who ordered Afluria may be able to begin vaccinating patients as early as this month, the company said. BioCSL will deliver close to 16.5 million doses of the formulation, with 75% of the doses in thimerosal-free pre-filled syringes.



“Our historical operational focus on early and consistent delivery has resulted in a strong customer prebook order demand for the coming season,” said Dr. Marie Mazur, president of bioCSL Inc. “We are committed to continuing to serve the needs of providers in the United States, and want to ensure that they are prepared to help prevent influenza in their communities.”



Afluria is approved for use in persons 5 years of age and older.